# The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease

> **NCT01687790** · NA · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 60 (actual)

## Conditions studied

- Breast Abnormalities

## Interventions

- **DEVICE:** molecular breast imaging (Discovery)

## Key facts

- **NCT ID:** NCT01687790
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01687790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01687790, "The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01687790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*